Follicum announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia patients (patients with hair loss). The company expects to be ready for starting the clinical trial shortly after the turn of the year. Preparations for the clinical trial are ongoing and through the agreement with the German company proDERM the completion of the study has been secured. proDERM specializes in conducting clinical studies with a focus on hair studies and has the necessary prerequisites for conducting clinical trials meeting the highest quality requirements. The remaining preparations for the study are also proceeding according to plan, which means that Follicum, unless something unforeseen occurs, will be able to start the upcoming clinical study shortly after the turn of the year.